baber/WOPTO huggingface dataset:
Patent CA-2373677-A1 (CA)
Title: Eponge de nettoyage manuel
Inventor: TERCELJ SCHWEIZER ROBERT
IPC: A47L17/04
Filed: 2000-05-17
Abstract: L'invention concerne une éponge de nettoyage permettant de laver de la vaisselle de manière simple et efficace, notamment des verres, des coupelles et des ustensiles étroits et profonds. L'éponge de nettoyage de l'invention comporte un corps (1) présentant une partie inférieure (3) et une ou plusieurs faces (2) latérales verticales, qui comporte(nt) au moins partiellement une partie (4) sensiblement réduite présentant des dimensions transversales qui diminuent à partir de la partie inférieure (3).
Patent CA-2374525-A1 (CA)
Inventor: FREITAS WALTER M
IPC: C04B24/32
Filed: 2000-05-26
Abstract: A method for improving early strength of cements comprising introducing into a cement, preferably during the grinding thereof, (a) at least one water reducer comprising a polyoxyalkylene polymer; (b) a sugar; and (c) an alkali or alkaline earth metal chloride. In further exemplary embodiments, the polyoxyalkylene polymer preferably comprises a comb polymer having a backbone and pendant groups. Optionally, an amine may be included with the additives. Exemplary additives and cements and cementitious compositions, preferably blended cements, and more most preferably pozzolanic cements, comprising the additives are also disclosed.
Patent CA-2374736-A1 (CA)
Title: Controlling media selection in printing
Inventor: GUARINO KEVIN J
IPC: G06F3/12
Filed: 2001-05-11
Abstract: A method (Fig. 1) for mapping logical sup-ply IDs and physical media supplies in a printer, so that the printer may receive a job stream and correctly select media from the correct supplies.     For two-letter codes and other abbreviations, refer to the "Guid-ance Notes on Codes and abbreviations" appearing at the begin-ning of each regular issue of the PCT Gazette.
Patent CA-2376916-A1 (CA)
Title: Formulation anesthesique comprenant un antagoniste nmda et un agoniste alpha-2 adrenergique
Inventor: MAZE MERVYN
IPC: A61P23/02
Filed: 2000-06-09
Abstract: L'invention concerne une composition pharmaceutique avec une formulation comprenant un antagoniste NMDA et un agoniste alpha-2 adrénergique. Dans un mode de réalisation préféré, l'invention concerne un anesthésique amélioré comprenant un antagoniste NMDA et un agoniste alpha-2 adrénergique.
Patent CA-2378002-A1 (CA)
Inventor: CABOS CLAUDE
IPC: C07C33/30
Filed: 2000-07-07
Abstract: The invention concerns novel methods for preparing enatiopure compounds of formula (I) (see formula I) wherein X represents a halogen atom, its additive salts with mineral or organic acids, or its salts with optically active organic acids. The invention also concerns intermediate compounds of formulae (II); (IV), (V), (VI), (VII), (XIII), (XIX) and (XX).  The invention further concerns enantiomerically pure compounds of formula (I), in the form of optically active salt with optically active organic acids.
Patent CA-2378267-A1 (CA)
Title: Non-crystalline cefuroxime axetil solid dispersant, process for preparing same and composition for oral administration thereof
Inventor: WOO JONG SOO
IPC: A61K47/00
Filed: 2000-07-25
Abstract: A non-crystalline cefuroxime axetil solid dispersant is prepared by (a) dissolving cefuroxime axetil and a surfactant in an organic solvent; (b) suspending a water-insoluble inorganic carrier in the resulting solution; an d (c) drying the resulting suspension to remove the organic solvent, said soli d dispersant having an improved bioavailability and stability of cefuroxime axetil and being useful for the preparation of a pharmaceutical composition for oral administration.
Patent CA-2378733-A1 (CA)
Title: Hydroformed collapsible drive shaft and steering shaft and methods of making the same
Inventor: JAEKEL FEDERICO G
IPC: B21D15/03
Filed: 2000-08-18
Abstract: A collapsible drive shaft (20) and method of making the same. The collapsible drive shaft (20) includes a tubular member having first (24) and second (22) portions that are integrally formed as a one-piece member. The first portion has splines (26) formed on an exterior surface thereof. The second (22), opposite portion has both outer (Do2) and inner diameters (Di2) that are greater than the outer diameter (Do 1) of the first portion. The method includes placing a tubular metal blank into a hydroforming die (70) having a die cavity and expanding the blank by pressurizing the interior of the blank with hydroforming fluid. During the hydroforming process, the first portion of the blank is expanded to form splines while the second portion is expanded to form inner and outer diameters that are greater than the outer diameter of the first portion.
Patent CA-2378847-A1 (CA)
Title: Shoe press device for pressing a wet fibre web, and a method for pressing a wet fibre web at high machine speeds
Inventor: ERIKSSON JONAS
IPC: D21F3/02
Filed: 2000-06-08
Abstract: A shoe press device (200) for pressing a wet fibre web, comprising a first press surface (201), a second press surface in the form of a flexible belt (202), and at least one press shoe (203). The first press surface and the press shoe form a press nip (204) having an effective pressure zone (205) during the pressing. The press shoe comprises at least one supply area (207)  for a pressurized lubricant. A heat transport connection (208, 209) is integrated in the press shoe for controlling the temperature of the lubrican t and the flexible belt within and after the effective pressure zone during th e pressing, and comprises at least one outlet (208) for removing lubricant, heated in the effective pressure zone (205) during the pressing, in close proximity to or immediately downstream the end of the effective pressure zon e. Furthermore, a method for pressing by means of the shoe press device, which is particularly advantageously implemented for pressing paper webs intended for  liner, paperboard, printing paper, newsprint, tissue paper, or the like, at machine speeds exceeding 1500 m/min.
Patent CA-2381632-A1 (CA)
Inventor: SWAILE DAVID FREDERICK
IPC: A61K8/00
Filed: 2000-02-24
Abstract: Disclosed are antiperspirant compositions which comprise from about 0.1% to about 50% by weight of solubilized antiperspirant active (e.g., aluminum- containing active or aluminum-zirconium containing active); and from about 0.1% to about 99.9% by weight of a liquid polyol having at least 2 hydroxyl groups, wherein 2 hydroxyl groups are attached to the .alpha. and .beta. carbons of the liquid polyol and no more than 4 hydroxyl groups are attached  to adjacent carbon atoms; a water-soluble, neutral amino acid; and a chlorin e- containing inorganic acid; wherein the liquid polyol has a ClogP value of le ss than about 2.0, wherein the mole ratio of the neutral amino acid to the zirconium and aluminum is from about 0.09 to about 0.24, the mole ratio of t he liquid polyol to the aluminum and zirconium is at least about 2.0:1, and the  mole ratio of the zirconium and aluminum to chlorine is less than about 1.30:1. These antiperspirant compositions and corresponding methods of application provide improved antiperspirant efficacy, cosmetics, and mildnes s, and can be prepared by simpler, more efficient, manufacturing methods. These  compositions can also be used as base or intermediate materials to formulate  other antiperspirant product forms providing similar performance benefits.</ SDOAB>
Patent CA-2381713-A1 (CA)
Title: Methods and compositions for reducing serum phosphate levels
Inventor: OTAKA AKIRA
IPC: A61K38/00
Filed: 2000-08-17
Abstract: Peptidic compounds which significantly reduce serum phosphate levels, and which, in addition, reduce bone loss or weakening are provided by the invention. Also provided is a method for treating or preventing any conditio n associated with elevated serum phosphate levels by administering the peptidi c compounds by oral or injectable means.
Patent CA-2382052-A1 (CA)
Title: A single sideband spread spectrum generator using hilbert transform
Inventor: MOSS JONATHAN GUY OWEN
IPC: H04B1/707
Filed: 2000-08-03
Abstract: This invention relates to a signal generator and decoder for a single sideband spread spectrum signal.   The present invention provides a single sideband spread spectrum signal generator and decoder in which single sideband modulation using a complex spreading code is achieved with improved correlation properties, so that the interference between users is reduced.
Patent CA-2384422-A1 (CA)
Title: Method for producing a tablet made of isomaltulose, isomalt or isolmalt variants
Inventor: RIFFEL PETER
IPC: A23L27/30
Filed: 2000-09-09
Abstract: The invention relates to a method for producing an improved tablet whereby said constituents are agglomerated. The invention also relates to a tablet produced according to the above method.
Patent CA-2385240-A1 (CA)
Title: Procede de transformation electrolytique du furane ou de ses derives
Inventor: PUTTER HERMANN
IPC: C25B3/00
Filed: 2000-09-15
Abstract: Procédé de transformation électrolytique d'au moins un dérivé du furane (A) suivant un cycle d'électrolyse comprenant les deux étapes (I) et (ii) ci-après : (i) oxydation électrolytique du furane ou d'un furane substitué ou d'un mélange renfermant ces deux ou plusieurs de ces composés, avec conservation (a) d'au moins un dérivé du furane (B) présentant une double liaison C-C dans un noyau hétérocyclique à 5 chaînons, et (b) d'hydrogène, (ii) hydrogénation de la double liaison C-C en utilisant l'hydrogène obtenu à la cathode, parallèlement, dans l'étape (i), ou de l'hydrogène provenant de l'extérieur à partir du cycle d'électrolyse, ou encore, hydrogénation électrocatalytique, caractérisé en ce que le procédé est effectué dans une cellule d'électrolyse comprenant au moins un catalyseur d'hydrogénation.
Patent CA-2386873-A1 (CA)
Title: Compositions polymeriques et leur procede de preparation
Inventor: BIENIARZ CHRISTOPHER
IPC: A61K9/20
Filed: 2000-10-30
Abstract: L'invention concerne une composition polymérique bioérodable, un procédé de préparation de cette composition, ainsi qu'un dispositif d'administration régulée comprenant cette composition.
Patent CA-2389125-A1 (CA)
Title: Method of and apparatus for removing a protective film applied to the surface of a handrail for an escalator or moving walkway
Inventor: MCLEOD JOHN
IPC: B66B23/24
Filed: 2000-02-18
Abstract: A film and a method of applying the film to a handrail of an escalator or moving walkway are provided. The film can be a single or double layered film. Printed matter, e.g. advertising, can be applied to or between the films. An apparatus and related method for applying the film are also included and rely on the motion of the handrail to unroll a supply of the film, with one or more rollers pressing the film onto the handrail.
Patent CA-2389610-A1 (CA)
Inventor: BOUDIERE GERARD
IPC: H01M8/04119
Filed: 2001-11-12
Abstract: The invention concerns two separators (20, 30) in series in the output portion of a hydrogen circuit defining each at least an intake chamber (21, 31), separated by a hydrophilic filter (22, 32), from an output chamber (23, 33) connected to the water circuit (24) of the cell. The invention is applicable to air-hydrogen fuel cells.
Patent CA-2389892-A1 (CA)
Title: Device of wind electric power on transportation vehicles
Inventor: TSENG DA-CHEN
IPC: B60K16/00
Filed: 2002-06-07
Abstract: A device of wind electric power on transportation vehicles comprises at least one wind electric power-generating unit, the air inlet of which faces the windward side of the electric vehicle. The wind electric power-generating unit is connected to a rechargeable secondary battery in which stores input electricity generated by wind power to replenish power supply of the electric vehicle. The air inlet of the wind electric power-generating unit has a pair of air throttles that are controlled by a driving unit and can be pushed outwards to enlarge cross section area of said air inlet to help gather airflow when the vehicle is running.
Patent CA-2390951-A1 (CA)
Inventor: O'LEARY CLEMENT ASHTON
IPC: A47B91/06
Filed: 2002-06-20
Abstract: A furniture glide includes a cylindrical elastomeric body adapted for insertion into a tubular furniture leg. The body has a first end and a second end. An integrally formed bulbous support is positioned at the first end of the body. At least two integrally formed discrete engagement members are positioned at the second end of the body with a centrally positioned gap between the at least two engagement members.      Upon insertion of a pressure member into the gap when the second end of the body is positioned within the tubular furniture leg, the at least two engagement members are forced outwardly and into engagement with the tubular furniture leg.
Patent CA-2394229-A1 (CA)
Title: Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy
Inventor: ROCHEFORT DANIEL
IPC: C12Q1/68
Filed: 2000-11-24
Abstract: The present invention relates to epilepsy. More particularly, the present invention relates to idiopathic generalized epilepsy (IGE) and to the identification of three genes mapping to chromosome 2, which show mutations in patients with epilepsy.  The invention further relates to nucleic acid sequences, and protein sequences of these loci (SCNA) and to the use thereof to assess, diagnose, prognose or treat epilepsy, to predict an epileptic individual's response to medication and to identify agents which modulate the function of the SCNA. The invention provides screening assays using SCN1A, SCN2A and/or SCN3A which can identify compounds which have therapeutic benefit for epilepsy and related neurological disorders. In a particular embodiment, the invention provides a method for identifying, from a library of compounds, a compound with therapeutic effect on epilepsy or other neurological disorders comprising: providing a screening assay comprising a measurable biological activity of SCN1A, SCN2A or SCN3A  protein or gene; contacting this screening assay with a test compound; and detecting if the test compound modulates the biological activity of SCN1A, SCN2A or SCN3A protein or gene; wherein a test compound which modulates the biological activity thereof is a compound with the desired therapeutic effect.
Patent CA-2394888-A1 (CA)
Title: Compose et procede de traitement de la douleur
Inventor: MURPHY MEGAN
IPC: A61K31/5025
Filed: 2000-12-19
Abstract: L'invention porte sur un composé, le 7-chloro-4-hydroxy-2-(2-chloro-4-methylphényl)-1,2,5,10-tétrahydropyridazino[4,5-b]quinoline-1,10-dione, sur ses sels pharmacocompatibles, sur un procédé de traitement de la douleur consistant à administrer une dose à effet analgésique dudit composé, et sur des préparation pharmaceutiques le contenant.
Patent CA-2396939-A1 (CA)
Title: Method for providing and processing locality information in switched networks
Inventor: DASSOW HEIKO
IPC: H04W4/02
Filed: 2000-12-22
Abstract: The invention relates to a method for providing and processing locality information in switched networks (1 to 3). The aim of the invention is to overcome the problem of conventional switching methods of connections, where by said methods depend on the origins. A uniform method which is compatible wit h conventional network architectures is provided for providing the information  on locations. The existing signalling protocols which are partially standardised do not require modification. Different networks (1 to 3) can be  interconnected by means of different methods for determining co-ordinates an d in a particularly simple manner and a service extending beyond one network i s possible by virtue of the selected architecture and the separation during transmission of signalling information and geographic co-ordinates.
Patent CA-2399972-A1 (CA)
Inventor: CHELNIK MARC
IPC: G07B15/02
Filed: 2001-02-01
Abstract: La présente invention concerne un procédé et un appareil de contrôle efficace et précis d'un parc de stationnement afin de vérifier que les véhicules qui y sont garés le sont légitimement. Une fois qu'une voiture est garée avec sa vignette d'identification, un contrôle de stationnement est effectué par balayage de la vignette. Une base de données est interrogée afin d'y trouver des informations de stationnement appropriées relatives à la vignette (125). Le droit au stationnement du véhicule est vérifié (129) et une action appropriée est entreprise (130).
Patent CA-2403052-A1 (CA)
Inventor: NGUYEN CLARK T C
IPC: H01G5/06
Filed: 2001-06-11
Abstract: L'invention concerne un dispositif micromécanique à coefficient <I>Q </I>élevé, tel qu'un condensateur, et un procédé de réglage de ce dispositif au moyen du déplacement électrostatique du diélectrique du condensateur. Ce condensateur micromécanique réglable à coefficient <I>Q</I> élevé est réalisé au moyen d'une technologie de micro-usinage de surface à plaque électrolysée compatible IC, et présente des facteurs de qualité (<I>Q-</I>) supérieurs à 290, qui est la valeur la plus élevée relevée jusqu'à ce jour pour des condensateurs réglables sur puce à des fréquences proches de 1GHz. Lorsque ces condensateurs réglables sont combinés avec des inducteurs à coefficient <I>Q</I> élevé sur puce (ou hors puce), ils peuvent s'avérer utiles non seulement pour des applications VCO intégrées à faible bruit de phase, mais aussi pour des filtres RF réglables à faible perte et des réseaux de correspondance réglables, les deux fonctions clés pouvant améliorer la programmabilité multibandes des combinés de communications sans fil. La caractéristique clé de cette conception, qui permet d'obtenir un tel coefficient <I>Q</I> sur puce élevé, est le procédé de réglage capacitif, qui est basé sur le déplacement du diélectrique entre les plaques du condensateur, plutôt que sur le déplacement des plaques elles-mêmes, comme c'était le cas pour les conceptions précédentes. Dans un mode de réalisation, on obtient un coefficient <I>Q </I>mesuré de 291 à 1GHz (C=1,21pF) avec une gamme de réglage de 7,7 % sur 10V de tension de commande et une fréquence propre attendue de 19 GHz. Dans un autre mode de réalisation, on obtient, pour une gamme de réglage plus large de 40 % sur 10V, un coefficient <I>Q</I> de 218 à 1 GHz (C=1,14pF).
Patent CA-2403580-A1 (CA)
Inventor: DAR OFER
IPC: G07B15/02
Filed: 2001-02-19
Abstract: L'invention concerne un procédé et un système de services liés à un véhicule, faisant appel à au moins un capteur détectant automatiquement au moins une durée, pendant laquelle un véhicule ne roule pas et est stationné, et à au moins une machine de traitement de données recevant les informations détectées par le capteur. Cette machine indique au moins une durée pendant laquelle un véhicule ne roule pas et est stationné, et elle fournit des données de facturation dans le cadre d'un service lié au véhicule, qui dépend d'au moins une durée pendant laquelle un véhicule ne roule pas et est stationné.
Patent CA-2406979-A1 (CA)
Title: Indole derivatives with vascular damaging activity
Inventor: BLAKEY DAVID CHARLES
IPC: A61P43/00
Filed: 2001-05-25
Abstract: The invention provides a compound of Formula (I) wherein: R1 and R2 are independently selected from hydrogen, halogen, -CN, a hydrocarbyl group or a group of Formula (II); wherein W is aryl or a heterocyclic group, R4 is independently selected from hydrogen, halogen, -OH, amino, alkanoylamino, -OPO3H2, or a hydrocarbyl group, wherein the amino group is optionally substituted by an amino acid residue and the hydroxy group is optionally esterified or two R4 groups together form an optionally substituted cyclic or heterocyclic group; X is selected from $M(y) S+-, +-O-+, -+S(O)+-, -+S(O2)+-and -+NH--; p is an integer from 0 to 4; and q is an integer from 1 to 4; R3 and R10 are independently selected from hydrogen, lower alkyl or a group of Formula (IV): wherein Y is selected from + NH+-, - $M(Y)O$M(Y)- or a bond; Z  is selected from + NH+-, -+O.upsilon.-, -+C(O)+- or a bond; r is an integer from 0 to 4; t is an integer from 0 to 1; R6 is hydrogen, a hydrocarbyl group or a group of Formula (V): wherein n is an integer of from 1 to 6, and; R7 and R8 are independently selected from hydrogen or a hydrocarbyl group; and R11 is hydrogen or lower alkyl; or a salt or solvate thereof; provided that: I) when R1 is an unsubstituted phenylthio group (Ph-S-), R2 is H, R10 is H and R11 is H then R3 is neither H nor- C(O)-O-CH2CH3; and ii) R1, R2 and R3 are not all hydrogen. Such compounds are predicted to cause the selective destruction of tumour vasculature. They may therefore be used to inhibit and/or reverse, and/or alleviate symptoms of angiogenesis and/or any disease state associated with angiogenesis.
Patent CA-2409058-A1 (CA)
Inventor: KLEINERT JAMES M
IPC: A41D19/02
Filed: 2002-10-21
Abstract: A glove includes a plurality of separated elongated sections to receive a plurality of fingers and a thumb therein, said elongated finger sections being tapered toward a longitudinal axis extending between a long finger section and a ring finger section so that when the elongated finger sections are in a flexed condition, the finger sections point to an area of the wrist including the scaphoid. 13
Patent CA-2409525-A1 (CA)
Inventor: SILVER SCOTT HUGH
IPC: D03D27/08
Filed: 2002-10-23
Abstract: A terry fabric having increased static and dynamic absorbency includes a ground fabric having opposing first and second surfaces and woven from ground warp yarns and ground fill yarns, each of the ground warp yarns and ground fill yarns consisting of at feast one cellulosic fiber, and terry warp yarns interwoven with the ground warp yarns and ground fill yarns to form terry loops extending from opposing surfaces of the ground fabric, the pile yarns consisting of microfiber.
Patent CA-2409922-A1 (CA)
Title: Controller fail-over without device bring-up
Inventor: SAWDY DON
IPC: G06F11/00
Filed: 2001-04-16
Abstract: A method and apparatus for reducing the bring-up time upon a transfer of control. This is accomplished by performing the physical level access bring- up prior to fail-over or other transfer, on the devices which are only secondarily controlled by the controller. The media level access is performe d (122) only by the controller with primary control of the devices. Upon a failure (108) or transfer by the first controller, a media level access (122 ) can be immediately performed by the second controller without doing a physic al level access first, since this had been done prior to the fail-over or transfer.
Patent CA-2409929-A1 (CA)
Title: Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
Inventor: VOORHEES JOHN J
IPC: A61P31/04
Filed: 2001-05-22
Abstract: Acne-affected skin has been found to be accompanied by the presence of matrix-degrading enzymes such as MMPs and neutrophil elastase, induction of neutrophils, and a reduction in procollagen biosynthesis. This invention treats scarring and inflammation accompanying acne by administering, topically or systemically, at least one of (i) an inhibitor of the matrix degrading enzymes and (ii) a cytokine inhibitor that alleviates inflammation and thus also alleviate neutrophil infiltration. Alleviating the matrix degradation and renormalizing procollagen biosynthesis allows for reduced inflammation and better natural repair of acne-affected skin. Inhibiting cytokines alleviates induction of MMPs is resident skin cells, and also alleviates inflammation with its concommitant induction of neutrophils from the blood stream bringing MMPs and elastase into the acne lesion. Diminishing the presence of matrix-degrading enzymes in the acne lesion reduces imperfect repair of the skin and thus decreases scarring in acne-affected skin.